Buy Byetta (Exenatide) Injectable Pens
$160.00 – $240.00
Please Note:
As part of our commitment to safe and responsible use, you must be 19 years of age or older to enter this site. It is illegal for a person under 19 years of age to purchase or attempt to purchase anything from insulining.com; and it is illegal to purchase for minors. All sales are conditional on the purchaser and recipient being of legal age. For information about age restriction, please contact Us
Buy Byetta (Exenatide) Injectable Pens is used with a proper diet and exercise program to control high blood sugar. People with type 2 diabetes use it. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke.
Exenatide is a diabetes drug that is similar to a natural hormone in your body (incretin). It works by increasing insulin release (especially after a meal) and decreasing the amount of sugar your liver makes. It also slows down food digestion in your stomach, reduces the amount of sugar absorbed from food, and may help decrease your appetite.
Studies have shown that GLP-1 reduces appetite and helps patients with weight loss (similar to Ozempic, Trulicity and Saxenda).
Buy Byetta (Exenatide) Injectable Pens Diet and exercise are usually recommended as part of treatment to improve glycemic control.
Byetta is currently not approved or considered safe for children.
Byetta contains the active substance exenatide. It is an injectable medication used to improve blood glucose control in adults with type 2 diabetes mellitus (non-insulin-dependent).
Exenatide is a glucagon-like peptide-1 receptor agonist (GLP-1) that exhibits several anti-hyperglycemic actions of glucagon-like peptide-1 (GLP-1). The amino acid sequence of exenatide partially overlaps that of human GLP-1. Exenatide has been shown to bind and activate the known human GLP-1 receptor in vitro, its mechanism of action being mediated by cyclic AMP and/or other intracellular signaling pathways.
Exenatide increases glucose-dependent insulin secretion from the beta cells of the pancreas. As the blood glucose concentration decreases, insulin secretion returns to normal. When exenatide was used in combination with metformin alone, no increase in the incidence of hypoglycemia was observed compared to placebo in combination with metformin that could be due to this glucose-dependent insulinotropic mechanism.
Exenatide suppresses glucagon secretion, which is known to be abnormally elevated in type 2 diabetes. Low concentrations of glucagon lead to decreased hepatic glucose production. However, exenatide does not affect the normal response of glucagon or other hormones to hypoglycemia.
Exenatide slows gastric emptying and therefore reduces the rate at which glucose derived from food appears in the circulation.
| select quantity | 10mg pen, 5mg pen, 2mg pen |
|---|
Related products
Insulin
Insulin
Insulin
Insulin
Diabetes Supplies
Diabetes Supplies
Insulin
Insulin
Insulin
Insulin
Diabetes Supplies
Insulin
Insulin